BrightSpring Health Services (NASDAQ:BTSG) Releases Earnings Results, Beats Expectations By $0.07 EPS

BrightSpring Health Services (NASDAQ:BTSG) issued its earnings results on Friday. The company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.47 by $0.07, FiscalAI reports. The business had revenue of $4.21 billion during the quarter, compared to analysts’ expectations of $3.88 billion. BrightSpring Health Services had a net margin of 2.55% and a return on equity of 16.73%. BrightSpring Health Services’s revenue for the quarter was up 26.4% compared to the same quarter last year.

Here are the key takeaways from BrightSpring Health Services’ conference call:

• Strong third-quarter performance: Revenue rose 26% year over year to $4.2 billion, adjusted EBITDA increased 42% to $228 million, and adjusted EPS grew 80% to $0.54. Results exceeded the company’s forecast, supported by broad-based growth across Pharmacy Solutions and Provider Services.
• Specialty and infusion pharmacy revenue grew 34%, driven by 29% script growth, strong branded limited-distribution drug launches, generic contributions, pharma services, and mid-teens growth in acute and chronic infusion. BrightSpring launched seven additional LDDs during the quarter and now supports 162 total therapies.
• Provider Services revenue increased 31%, with home health census up approximately 58% and continued momentum in rehab and personal care. Management expects the acquired Amedisys and LHC branches to contribute approximately $35 million of adjusted EBITDA in 2026.
• BrightSpring raised or reaffirmed a strong outlook, projecting 2026 adjusted EBITDA of $850 million-$860 million and more than $700 million of operating cash flow, while reiterating expectations for at least 15%-20% organic adjusted EBITDA growth in 2027. Leverage declined to 1.79 times, including the impact of $120 million in year-to-date share repurchases.
• Home and community pharmacy revenue declined 6% year over year, primarily because of approximately $50 million of quarterly impact from the Inflation Reduction Act and exits from uneconomic customers. Management expects the IRA to remain a roughly $50 million headwind in the fourth quarter, although underlying growth and profitability are improving.

BrightSpring Health Services Stock Up 11.1%

BrightSpring Health Services stock opened at $66.89 on Friday. The company has a debt-to-equity ratio of 1.06, a quick ratio of 1.22 and a current ratio of 1.59. The company has a market capitalization of $13.23 billion, a PE ratio of 36.16, a price-to-earnings-growth ratio of 0.87 and a beta of 1.87. BrightSpring Health Services has a fifty-two week low of $30.64 and a fifty-two week high of $73.75. The firm has a 50 day moving average price of $59.94 and a 200 day moving average price of $54.54.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. UBS Group upped their price objective on shares of BrightSpring Health Services from $63.00 to $85.00 and gave the company a “buy” rating in a research note on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $70.00 target price on shares of BrightSpring Health Services in a research note on Monday, August 3rd. KeyCorp restated an “overweight” rating on shares of BrightSpring Health Services in a report on Monday, August 3rd. BTIG Research restated a “buy” rating and issued a $90.00 price target on shares of BrightSpring Health Services in a research report on Thursday, August 13th. Finally, Wells Fargo & Company increased their price target on BrightSpring Health Services from $61.00 to $78.00 and gave the company an “overweight” rating in a report on Monday, July 13th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $72.88.

BrightSpring Health Services News Roundup

Here are the key news stories impacting BrightSpring Health Services this week:

• Positive Sentiment: Third-quarter earnings exceeded expectations. BrightSpring reported adjusted earnings of $0.54 per share, up from $0.30 a year earlier and above analyst estimates ranging from $0.47 to $0.49. This marked another quarterly earnings beat for the company. BrightSpring Q3 earnings and revenue results
• Positive Sentiment: Revenue growth was substantially stronger than forecast. Quarterly revenue rose 26.4% year over year to $4.21 billion, surpassing the $3.88 billion consensus estimate. The revenue performance indicates continued expansion across BrightSpring’s healthcare services platform. BrightSpring Q3 revenue report
• Positive Sentiment: Management increased full-year 2026 guidance. BrightSpring raised its revenue and adjusted EBITDA outlook, reinforcing investor confidence that operating momentum and profitability will remain strong. BrightSpring reports Q3 results and raises guidance
• Positive Sentiment: Profitability improved. BrightSpring posted a 16.73% return on equity and a 2.55% net margin, while the earnings beat and stronger revenue helped support the positive market reaction. BrightSpring bottom-line results

About BrightSpring Health Services

BrightSpring Health Services (NASDAQ:BTSG) is a Louisville, Kentucky-based provider of home- and community-based health services and pharmacy services. The company focuses on supporting individuals with complex or chronic care needs, including older adults and people with disabilities, through care delivered in homes, communities and other non-hospital settings.

Its services include home health, hospice, personal care, behavioral health, primary care, rehabilitation and community living programs.